Journal of Heterocyclic Chemistry · 1997 · 14 citations · 6 references
PharmacyChemistryMedicinal ChemistryDrug DiscoveryOrganic ChemistrySynthetic Medicinal ChemistryHeterocycle SynthesisHeterocyclic ChemistryLead Compound DesignMacrocycle SynthesisOrganic SynthesisRetrosynthetic AnalysisFluoroquinolone AntibioticsQuinoline ChemistryQuinoline SynthesisQuinone ChemistryRegioselective Deprotection
Abstract A practical synthesis of ethyl 6,7‐difluoro‐1‐methyl‐4‐oxo‐4 H ‐[1,3]trüazeto[3,2‐ a ]quinoline‐3‐carboxylate ( 9 ), the key intermediate for 6‐fluoro‐1‐methyl‐7‐[4‐(5‐methyl‐2‐oxo‐1,3‐dioxol‐4‐yl)methyl‐1‐piperazinyl]‐4‐oxo‐4 H ‐[1,3]thiazeto[3,2‐ a ]quinoline‐3‐carboxylic acid ( 2 ), NM441, was developed. The crucial points of this synthetic route are the chlorination of ethyl 4‐acetoxy‐2‐(ethylthio)‐6,7‐difluoroquinoline‐3‐carboxylate ( 12 ) and the subsequent deacetylation of the resulting 2‐(l‐chloroethyl)thio compound 13 followed by the intramolecular cyclization reaction. Versatile new syntheses of 2‐thioquinoline skeleton were also developed. The first route includes the intramolecular cyclization of the N,S ‐acetal 22 which was prepared from 2,4,5‐trifluorobenzoic acid in three steps. The second one contains the regioselective attack of lithium etiolate of ethyl acetate to the novel 2‐(methylthio)‐4 H ‐[3,l]benzothiazine‐4‐one 29 at the 4‐position followed by the intramolecular cyclization of the resulting β‐ketoester 30 .
6
Jun Segawa, Masahiko Kitano, Kenji Kazuno et al. · Journal of Medicinal Chemistry · 1992 · 47 citations
Jun Segawa, Masahiko Kitano, Kenji Kazuno et al. · Journal of Heterocyclic Chemistry · 1992 · 17 citations